Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. News
Inspire Medical Systems, Inc. Quantitative Score
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Inspire Medical Systems, Inc. Financials
Table Compare
Compare INSP metrics with: | |||
|---|---|---|---|
Earnings & Growth | INSP | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | INSP | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | INSP | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | INSP | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Inspire Medical Systems, Inc. Income
Inspire Medical Systems, Inc. Balance Sheet
Inspire Medical Systems, Inc. Cash Flow
Inspire Medical Systems, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Inspire Medical Systems, Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 9.0000 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| TBA | 9 | Quarterly |
Historical Market Cap
Shares Outstanding
Inspire Medical Systems, Inc. Executives
| Name | Role |
|---|---|
| Mr. Timothy P. Herbert | Founder, Chairman, Chief Executive Officer & President |
| Mr. Carlton W. Weatherby | Chief Strategy and Growth Officer |
| Mr. Randall A. Ban | EVice President of Patient Access &Therapy Development |
| Mr. Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
| Mr. Richard J. Buchholz | Chief Financial Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Timothy P. Herbert | Founder, Chairman, Chief Executive Officer & President | Male | 1963 | 1.55M |
| Mr. Carlton W. Weatherby | Chief Strategy and Growth Officer | Male | 1985 | 809.59K |
| Mr. Randall A. Ban | EVice President of Patient Access &Therapy Development | Male | 1965 | 754.16K |
| Mr. Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary | Male | 1971 | 737.03K |
| Mr. Richard J. Buchholz | Chief Financial Officer | Male | 1968 | 728.16K |
Inspire Medical Systems, Inc. Insider Trades
| Date | 15 Jul |
| Name | Ellis Gary Lee |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 221 |
| Date | 15 Jul |
| Name | Tansey Casey M |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 133 |
| Date | 15 Jul |
| Name | Broader Shelley G |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 148 |
| Date | 15 Jul |
| Name | Melenikiotou Georgia |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 131 |
| Date | 4 Jun |
| Name | mcCormick Shawn |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 4000 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 15 Jul | Ellis Gary Lee | Director | Acquired | A-Award | 221 |
| 15 Jul | Tansey Casey M | Director | Acquired | A-Award | 133 |
| 15 Jul | Broader Shelley G | Director | Acquired | A-Award | 148 |
| 15 Jul | Melenikiotou Georgia | Director | Acquired | A-Award | 131 |
| 4 Jun | mcCormick Shawn | Director | Acquired | M-Exempt | 4000 |